Know Cancer

or
forgot password

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer A Prospective Trial


N/A
45 Years
85 Years
Open (Enrolling)
Female
Advanced Breast Cancer

Thank you

Trial Information

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer A Prospective Trial


The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal
Women with Advanced Breast Cancer A Prospective Trial.


Inclusion Criteria:



- Receptor Positive Premenopausal Women with Advanced Breast Cancer.

Exclusion Criteria:

- Any woman other than diagnosis of Receptor Positive Premenopausal with Advanced
Breast Cancer.

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Principal Investigator

Al Sayed, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

KFSH & RC

Authority:

United States: Institutional Review Board

Study ID:

RAC# 2081-064

NCT ID:

NCT01311037

Start Date:

January 2009

Completion Date:

Related Keywords:

  • Advanced Breast Cancer
  • Premenopausal Women with Advanced Breast Cancer
  • Breast Neoplasms

Name

Location